Study of the safety of hyper immune bovine milk and colostrum against covid-19

Study of the safety of hyperimmune bovine milk and colostrum against covid-19

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200927048849N1

Enrollment

Registered

2020-12-05

Start date

2020-11-10

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19 viral pneumonia. Pneumonia due to SARS-associated coronavirus

Interventions

Intervention group: Healthy volunteers. After explaining the study and obtaining consent the intervention group will be given 100 cc of hyperimmune milk..

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Signing of consent form of the study Free of underlying disease Not having clinical signs of covid-19 infection

Exclusion criteria

Exclusion criteria: Diseased person Not having underlying disease

Design outcomes

Primary

Measure	Time frame
Incidence of clinical symptoms. Timepoint: From the first day of using until 14 days after that. Method of measurement: Questionnaire through phone interview.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayeh Sadeghi

Esfahan University of Medical Sciences

S.sadeghi117917@gmail.com+98 31 3261 6331

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026